CS988082A2 - - Google Patents

Info

Publication number
CS988082A2
CS988082A2 CS829880A CS988082A CS988082A2 CS 988082 A2 CS988082 A2 CS 988082A2 CS 829880 A CS829880 A CS 829880A CS 988082 A CS988082 A CS 988082A CS 988082 A2 CS988082 A2 CS 988082A2
Authority
CS
Czechoslovakia
Prior art keywords
oxoalkyl
carbon atoms
antiinflammatories
benzoyl
alpha
Prior art date
Application number
CS829880A
Other languages
Czech (cs)
English (en)
Inventor
Klaus Dr Annen
Karl Dr Petzoldt
Henry Dr Laurent
Rudolf Prof Dr Wiechert
Helmut Dr Hofmeister
Hans Dr Wendt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CS988082A2 publication Critical patent/CS988082A2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/06Hydroxylating
    • C12P33/08Hydroxylating at 11 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CS829880A 1981-08-18 1982-08-18 CS988082A2 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813133081 DE3133081A1 (de) 1981-08-18 1981-08-18 Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
CS988082A2 true CS988082A2 (fi) 1985-08-31

Family

ID=6139787

Family Applications (2)

Application Number Title Priority Date Filing Date
CS826061A CS244115B2 (en) 1981-08-18 1982-08-18 Method of 6 alpha-methyl-foresolonetz derivatives production
CS829880A CS988082A2 (fi) 1981-08-18 1982-08-18

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS826061A CS244115B2 (en) 1981-08-18 1982-08-18 Method of 6 alpha-methyl-foresolonetz derivatives production

Country Status (23)

Country Link
US (1) US4587236A (fi)
EP (1) EP0072547B1 (fi)
JP (1) JPS5874698A (fi)
AT (1) ATE18768T1 (fi)
AU (1) AU560160B2 (fi)
CA (1) CA1251783A (fi)
CS (2) CS244115B2 (fi)
DD (1) DD211566A5 (fi)
DE (2) DE3133081A1 (fi)
DK (1) DK160505C (fi)
ES (1) ES515081A0 (fi)
FI (1) FI72730C (fi)
GB (1) GB2105339A (fi)
GR (1) GR78361B (fi)
HU (1) HU186965B (fi)
IE (1) IE53753B1 (fi)
IL (1) IL66511A (fi)
LU (1) LU88289I2 (fi)
MX (1) MX9203687A (fi)
NO (1) NO156203C (fi)
NZ (1) NZ201544A (fi)
PT (1) PT75294B (fi)
ZA (1) ZA826017B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58103399A (ja) * 1981-12-11 1983-06-20 Ota Seiyaku Kk 6α−メチルプレドニゾロン17−エステル化合物
JPS58208299A (ja) * 1982-05-31 1983-12-03 Ota Seiyaku Kk 6α−メチルプレドニゾロン17,21−ジエステル化合物
EP0095894A3 (en) * 1982-05-31 1985-01-02 Ohta Seiyaku Kabushiki Kaisha. 6 alpha-methylprednisolone derivatives
JPS59193900A (ja) * 1983-04-15 1984-11-02 Ota Seiyaku Kk 新規6α−メチルプレドニゾロン17α−エステル誘導体
JPS597200A (ja) * 1982-07-02 1984-01-14 Ota Seiyaku Kk 6α−メチルプレドニゾロン17α−エステル化合物
DE3344834A1 (de) * 1983-12-08 1985-06-13 Schering AG, 1000 Berlin und 4709 Bergkamen Neue hydrocortison-und prednisolon-derivate
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Iv型ホスホジエステラーゼの阻害剤
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
US20110021473A1 (en) * 2006-09-22 2011-01-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CN100439388C (zh) * 2006-10-11 2008-12-03 汪家振 甲基泼尼松龙醋丙酸酯的合成方法
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN102659886A (zh) * 2010-04-20 2012-09-12 天津金耀集团有限公司 一种醋丙甲泼尼龙新晶型与制备方法
WO2011130877A1 (zh) * 2010-04-21 2011-10-27 天津金耀集团有限公司 醋丙甲泼尼龙一水合物晶型及其制备方法
GR1009641B (el) 2018-06-18 2019-11-12 Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. Ποσιμες συνθεσεις που περιλαμβανουν νατριοηλεκτρικη μεθυλοπρεδνιζολονη
CN111748010B (zh) * 2019-03-29 2023-12-08 天津药业研究院股份有限公司 一种醋丙甲泼尼龙无水晶型及其组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2897218A (en) * 1956-11-23 1959-07-28 Upjohn Co 6-methyl-1-dehydro analogues of cortisone, hydrocortisone and 21-esters thereof
US2867632A (en) * 1956-11-23 1959-01-06 Upjohn Co 6-methyl steroid compounds
US3053832A (en) * 1957-04-29 1962-09-11 Schering Corp Alkylated cortical steroids
US3176032A (en) * 1958-04-18 1965-03-30 Syntex Corp 17alpha, 21-diacyloxy derivatives of 6alpha-methyl-delta1, 4-pregnadien-3, 20-dione and of 6alpha-methyl-delta4-pregnen-3, 20-dione
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
NL6612191A (fi) * 1965-08-30 1967-03-01
US3422193A (en) * 1966-08-11 1969-01-14 Schering Corp 17-mono esters of corticoids
DE2144405A1 (de) * 1971-09-04 1973-03-08 Merck Patent Gmbh Verfahren zur herstellung von estern der pregnanreihe
JPS6040439B2 (ja) * 1978-03-29 1985-09-11 大正製薬株式会社 ヒドロコルチゾン誘導体
JPS5686119A (en) * 1979-12-17 1981-07-13 Taiho Yakuhin Kogyo Kk Steroid anti-inflammatory
DE3169460D1 (en) * 1980-12-23 1985-04-25 Schering Ag 6-alpha-methyl hydrocortisone derivatives, their preparation and their utilization
IL66432A0 (en) * 1981-08-04 1982-12-31 Plurichemie Anstalt Process for the preparation of steroidal esters
EP0095894A3 (en) * 1982-05-31 1985-01-02 Ohta Seiyaku Kabushiki Kaisha. 6 alpha-methylprednisolone derivatives

Also Published As

Publication number Publication date
GB2105339A (en) 1983-03-23
ATE18768T1 (de) 1986-04-15
LU88289I2 (fr) 1994-05-04
ZA826017B (en) 1983-07-27
AU8717782A (en) 1983-02-24
EP0072547A1 (de) 1983-02-23
DE3270118D1 (en) 1986-04-30
CS606182A2 (en) 1985-08-15
DE3133081A1 (de) 1983-03-10
DK160505C (da) 1991-08-26
PT75294B (de) 1984-07-02
ES8305380A1 (es) 1983-05-01
AU560160B2 (en) 1987-04-02
HU186965B (en) 1985-10-28
PT75294A (de) 1982-08-01
IL66511A (en) 1986-12-31
FI822871A0 (fi) 1982-08-18
JPH0149278B2 (fi) 1989-10-24
NO822799L (no) 1983-02-21
US4587236A (en) 1986-05-06
FI822871L (fi) 1983-02-19
ES515081A0 (es) 1983-05-01
GR78361B (fi) 1984-09-26
DD211566A5 (de) 1984-07-18
DK160505B (da) 1991-03-18
FI72730C (fi) 1987-07-10
DK369482A (da) 1983-02-19
CA1251783A (en) 1989-03-28
MX9203687A (es) 1992-08-01
NO156203C (no) 1987-08-12
IE53753B1 (en) 1989-02-01
IL66511A0 (en) 1982-12-31
NZ201544A (en) 1986-01-24
CS244115B2 (en) 1986-07-17
IE821988L (en) 1983-02-18
FI72730B (fi) 1987-03-31
NO156203B (no) 1987-05-04
JPS5874698A (ja) 1983-05-06
EP0072547B1 (de) 1986-03-26

Similar Documents

Publication Publication Date Title
IE821988L (en) 6ó-methylprednisolones
EP0165904A3 (en) Substituted bicycle compounds
JPS5716822A (en) Use of antipsychotic and adenosine derivative
AU548396B2 (en) 2-aryl-3,4-diazabicyclo(4.n.0)alk-2-en-5-ones
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
DE3266845D1 (en) Hydrocortisone derivatives, their preparation and their utilization
NZ212658A (en) Phenylnaphthyridine derivatives and pharmaceutical compositions
IL64614A (en) 6alpha-methylhydrocortisone derivatives,processes for their preparation and pharmaceutical compositions containing them
AU551901B2 (en) Substituted thienobenzodiazepinones
ES2011986A6 (es) Procedimiento para preparar derivados de ergolina.
ATE36536T1 (de) Phosphoroimidate.